Endocrine Diseases
9
4
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Diagnosis of Pheochromocytoma
Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Evaluation of Children With Endocrine and Metabolic-Related Conditions
Functional Status in Hospitalized Endocrine Disorders
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
Performance of the Diagnostic Value of Bone Age Assessment Software Based on Deep Learning in Chinese Children
Endocrine Studies in Health and Disease
Male:Female Birth Ratios and Phthalate Levels